Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jane Wasman Insider Profile
4 Followers
Jane Wasman, President, Intl and GC at Acorda Therapeutics, holds 10.40K shares in SELLAS Life Sciences Group (Ticker: SLS), holds 75.00K shares in Rigel (Ticker: RIGL), holds 35.14K shares in Athersys (Ticker: ATHXQ).
Jane Wasman Acorda Therapeutics (ACORQ)President, Intl and GC
Acorda Therapeutics (ACORQ)
President, Intl and GC
Ranked #79,149 out of 98,624 Corporate Insiders
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-29.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jane Wasman holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Aug 29, 2014 - Aug 29, 2015
Return:-0.40%
The most profitable trade made by Jane Wasman
Jane Wasman's Trading History
Acorda Therapeutics
Dec 04, 2019
President, Intl and GC
Uninformative Sell
3.54K
$85.72K
SELLAS Life Sciences Group
Jan 25, 2024
Director
Uninformative Buy
―
$15.18K
Rigel
Jul 12, 2023
Director
Uninformative Buy
―
$82.50K
Athersys
Jan 11, 2023
Director
Uninformative Buy
―
$351.41
List of latest transactions for each holding click on a transaction to see Jane Wasman's performance on stock
You May Also Like
Jane Wasman insider profile FAQ
What is the percentage of profitable transactions made by Jane Wasman?
The percentage of profitable transactions made by Jane Wasman is 0%.
What is the average return per transaction made by Jane Wasman?
The average return per transaction made by Jane Wasman is -29.40%.
What stocks does Jane Wasman hold?
Jane Wasman holds: ACORQ, SLS, RIGL, ATHXQ stocks.
What was Jane Wasman’s latest transaction?
Jane Wasman latest transaction was an Uninformative Buy of ―.
What was Jane Wasman's most profitable transaction?
Jane Wasman’s most profitable transaction was an Informative Sell of ACORQ stock on August 29, 2014. The return on the trade was -0.40%.
What is Jane Wasman's role in Acorda Therapeutics?
Jane Wasman's role in Acorda Therapeutics is President, Intl and GC.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.